GetTopicDetailResponse(id=021e11522955, topicName=多特異性抗體, introduction=, content=腫瘤 雙特異性 多特異性抗體, image=null, comments=0, allHits=902, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Wed Jun 05 18:02:02 CST 2024, time=2024-06-05, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=473596, tagList=[TagDto(tagId=473596, tagName=多特異性抗體)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2226675, encodeId=c8c822266e5c8, content=<a href='/topic/show?id=2ad83e51258' target=_blank style='color:#2F92EE;'>#雙特異性抗體#</a> <a href='/topic/show?id=021e11522955' target=_blank style='color:#2F92EE;'>#多特異性抗體#</a>, objectTitle=讀書(shū)報(bào)告 | 雙特異性抗體和多特異性抗體治療腫瘤的機(jī)遇和挑戰(zhàn), objectType=article, longId=842999, objectId=2c6884299947, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240726/1721988964751_8538692.jpg, objectUrl=/article/show_article.do?id=2c6884299947, replyNumber=0, likeNumber=95, createdTime=2024-09-19, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2c6884299947, moduleTitle=讀書(shū)報(bào)告 | 雙特異性抗體和多特異性抗體治療腫瘤的機(jī)遇和挑戰(zhàn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2c6884299947)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2208477, encodeId=37d622084e72c, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#腫瘤#</a> <a href='/topic/show?id=4fcf1152280a' target=_blank style='color:#2F92EE;'>#雙特異性#</a> <a href='/topic/show?id=021e11522955' target=_blank style='color:#2F92EE;'>#多特異性抗體#</a>, objectTitle=一作兼通訊，最新Nature系列綜述： 面向腫瘤的雙特異性和多特異性抗體—機(jī)遇與挑戰(zhàn), objectType=article, longId=828910, objectId=f95e828910d3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240605/1717572724953_5579292.png, objectUrl=/article/show_article.do?id=f95e828910d3, replyNumber=0, likeNumber=117, createdTime=2024-06-05, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f95e828910d3, moduleTitle=一作兼通訊，最新Nature系列綜述： 面向腫瘤的雙特異性和多特異性抗體—機(jī)遇與挑戰(zhàn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f95e828910d3)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-06-05發(fā)表于上海
